ARCHIVES OF

THE BALKAN MEDICAL UNION

The official journal of the Balkan Medical Union, since 1935

Citation Abbreviation:

Arch Balk Med Union

Infections and intestinal microbiome in ankylosing spondylitis: clinical, immunopathological, and management implications

0

Introduction. Ankylosing spondylitis (AS) is a chronic inflammatory disease predominantly affecting the axial skeleton, strongly associated with Human Leukocyte Antigen B27 (HLA-B27). Besides genetic predisposition, infectious triggers and intestinal dysbiosis are increasingly recognized as contributors to AS pathogenesis, although their integrated clinical relevance remains incompletely defined.
The objective of the study was to evaluate the prevalence of specific urogenital and enterocolitic infections in AS and their association with clinical phenotype and disease activity, and to characterize intestinal microbiota alterations in AS patients compared with healthy controls.
Material and methods. A cross-sectional case-control study included 316 AS patients (236 men, 80 women; mean age 41.17±8.82 years) and 124 matched healthy controls. The clinical assessment included Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Disease Activity Score (ASDAS), pain Visual Analog Scale (VAS), laboratory inflammatory markers, and radiographic scoring. Gut microbiota was analyzed by 16S rRNA gene sequencing.
Results. At least one infection was identified in 51% of AS patients, with Chlamydia trachomatis detected in 21.2%. Chlamydia-positive patients exhibited earlier peripheral arthritis onset and distinctive clinical features. The overall disease activity was high (mean BASDAI 5.8±1.4; ASDAS-CRP 2.61±0.57). Gut microbiota analysis revealed significant dysbiosis in AS versus controls (β-diversity p<0.001), characterized by enrichment of Prevotella, Dialister, and Collinsella and depletion of Bacteroides and Lachnospira. A random forest model differentiated AS from controls with >90% specificity.
Conclusions. AS is associated with a combined signature of intestinal dysbiosis and frequent asymptomatic infections, particularly Chlamydia trachomatis. These findings support a gut-joint-urogenital axis in AS pathogenesis and highlight microbial profiles as potential diagnostic and therapeutic targets.
Keywords: ankylosing spondylitis, dysbiosis, Chlamydia trachomatis, gut microbiota, reactive arthritis.

Address for correspondence:
Lia CHISLARI
“Nicolae Testemitanu” State University of Medicine and Pharmacy, Chisinau, Republic of Moldova
Address: Prigoreni str., 7/1, ap. 27, MD 2002, Chisinau, Republic of Moldova
Email: lia.chislari@usmf.md; Phone +37 379 544 280

Share.

Comments are closed.

Chislari L, Nestor M, Gorea M, Ciorescu C, Homitchi M, Russu E. Infections and intestinal microbiome in ankylosing spondylitis: clinical, immunopathological, and management implications. Arch Balk Med Union. 2026;61(1):66-76.

https://doi.org/10.31688/ABMU.2026.61.1.08

Exit mobile version